Adherence to antiretroviral therapy in resource-limited settings: Everything matters

AIDS

Volumn 21, Issue 8, 2007, Pages 1041-1042

  Hawkins, Claudia ^a   Murphy, Robert ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE COURSE; DRUG COST; EDITORIAL; FOLLOW UP; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIROTHERAPY;

ANTI-HIV AGENTS; DRUG ADMINISTRATION SCHEDULE; HEALTH CARE RATIONING; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; UGANDA;

EID: 34247594263     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3281900eb9     Document Type: Editorial

References (9)

1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14:357-366.
2. Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, Diakhate N, et al., for the ANRS 1215/1290 Study Group. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 2005; 38:14-17.
3. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3:e438.
4. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIVRUgandan patients purchasing therapy. Int J STD AIDS 2005; 16:38-41.
5. Crane JT, Kawuma A, Oyugi JH, Byakika JT, Moss A, Bourgois P, Bangsberg DR. The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav 2006; 10:437-442.
6. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007; 21:965-971.
7. Laurent C, Meilo H, Guiard-Schmid JB, Mapoure Y, Noël JM, M'Bangué M, et al. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala Antiretroviral (DARVIR) Initiative. Clin Infect Dis 2005; 41:108-111.
8. Iliyasu Z, Kabir M, Abubakar IS, Babashani M, Zubair ZA. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Niger J Med 2005; 14:290-294.
9. Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, et al. Response to antiretroviral therapy in HIVinfected patients attending a public health clinic in Kampala, Uganda. Clin Infect Dis 2006; 42:252-259.